Latham & Watkins LLP represented the underwriters in the offering. Foghorn Therapeutics Inc. has announced the pricing of its initial public offering of 7,500,000 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
